Multicenter, Prospective, Randomized Study Investigating the Efficacy and Safety of a Reduced Immunosuppressive Therapy With Tacrolimus Once Daily in Comparison to Standard Triple Immunosuppression in Senior Renal Transplant Recipients

Trial Profile

Multicenter, Prospective, Randomized Study Investigating the Efficacy and Safety of a Reduced Immunosuppressive Therapy With Tacrolimus Once Daily in Comparison to Standard Triple Immunosuppression in Senior Renal Transplant Recipients

Not yet recruiting
Phase of Trial: Phase IV

Latest Information Update: 12 Aug 2017

At a glance

  • Drugs Tacrolimus (Primary) ; Mycophenolate mofetil
  • Indications Renal transplant rejection
  • Focus Therapeutic Use
  • Acronyms REDUCE
  • Most Recent Events

    • 08 Aug 2017 Planned initiation date changed from 1 Feb 2017 to 1 Dec 2017.
    • 11 Aug 2016 Planned initiation date changed from 1 Jun 2015 to 1 Feb 2017.
    • 08 Jun 2015 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top